Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-298865

Chief Development Officer sold 20,000 shares at an average $93.13 ($1,862,530)

  • Chief Development Officer acquired 20,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Guyer William · Chief Development Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-07 Exercise or conversion : show line 1 in the form 10b5-1 +20,000 $21.65 $433,000 23,985 D
2026-07-07 Sale : show line 2 in the form 10b5-1 −19,048 $93.11 $1,773,481 4,937 D
2026-07-07 Sale : show line 3 in the form 10b5-1 −952 $93.54 $89,048 3,985 D
Open-market sales · 20,000 sh · avg $93.13 · $1,862,530

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-07 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (right to buy) −20,000 130,000 D
Loading xslF345X06/ownership.xml…